Toxic keratopathy

International Ophthalmology Clinics

Volumn 38, Issue 4, 1998, Pages 15-22

  DeRosa, Anthony J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; ATOVAQUONE; CHLORAMBUCIL; CYTARABINE; DOMESTIC CHEMICAL; FLUOROURACIL; INDUSTRIAL CHEMICAL; MITOMYCIN; NAPROXEN; NITROSOUREA DERIVATIVE; ORGANIC SOLVENT; SILICONE OIL; SURAMIN; SURFACTANT; TAMOXIFEN; TILORONE; VINCRISTINE;

DIAGNOSTIC APPROACH ROUTE; DRUG ABUSE; EYE SURGERY; EYE TOXICITY; KERATOPATHY; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

CORNEA; CORNEAL DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; OCCUPATIONAL EXPOSURE; OPHTHALMIC SOLUTIONS; SUBSTANCE-RELATED DISORDERS;

EID: 0032446744     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199803840-00004     Document Type: Review

References (57)

1. Stedman's Medical Dictionary. Baltimore: Williams and Wilkins, 1995;26:1826
2. Fraunfelder FT, Meyer SM. Corneal complications of ocular medications. Cornea 1986; 5:55-59
3. Fraunfelder FT, Meyer SM. Ocular toxicology. In: Tasman W, ed. Duane's clinical ophthalmology. Philadelphia: Lippincott, 1990:1-24
4. Houle RE, Grant WM. Zinc chloride keratopathy and cataracts. Am J Ophthalmol 1973; 75:992-996
5. Ballantyne B. The comparative short-term mammalian toxicology of phenarsazine oxide and phenoxarsine oxide. Toxicology 1978;10:341-361
6. Fraunfelder FT, Coster DJ, Drew R, Fraunfelder FW. Ocular injury induced by methyl ethyl ketone peroxide. Am J Ophthalmol 1990;110:635-640
7. Potts AM, Rouse EF, Eiferman RA, Au PC. An unusual type of keratopathy observed in Polyurethane workers and its reproduction in experimental animals. Am J Ind Med 1986;9:203-213
8. Bencz Z, Ivan E, Cholnoky E. Analysis of cataract and keratotic damage induced by 4-diethylaminoethoxy-alpha-ethyl-benzhydrol in rats. Arch Toxicol Suppl 1985;8:476-479
9. Ballantyne B, Gazzard MF, Swanston DW, Williams P. The comparative ophthalmic toxicology of 1-chloroacetophenone and dibenz(b.f.)-1:4-oxazepine (CR). Arch Toxicol 1975;34:183-201
10. Dahl AA, Grant WM. Unusual keratitis from a household remedy. Am J Ophthalmol 1969;68:858-862
11. Parker WT, Binder PS. Gentian violet keratoconjunctivitis. Am J Ophthalmol 1979; 87:340-343
12. Leibowitz, H. Corneal disorders. Clinical diagnosis and management. Chicago: Saunders, 1984:243-246
13. Pitts JF, Barker NH, Gibbons DC, Jay JL. Manchineel keratoconjunctivitis. Br J Ophthalmol 1993;77:284-288
14. Lisch K. The effect of the sap of Euphorbiaceae on the eye. Klin Monatsbl Augenheilkd 1980;176:469-471
15. Scott IU, Karp CL. Euphorbia sap keratopathy: four cases and a possible pathogenic mechanism. Br J Ophthalmol 1996;80:823-826
16. Egerer I. Ocular involvement due to the juice of Dieffenbachia plants. Klin Monastsbl Augenheilkd 1977;170:128-130
17. English F, Bennett Y. The challenge of mustard-gas keratopathy [letter]. Med J Aust 1990;152:55-56
18. Klingele TG, Alves LE, Rose EP. Amiodarone keratopathy. Ann Ophthalmol 1984;16: 1172-1176
19. Fraunfelder FT, Meyer SM. Amiodarone keratopathy. Trans Ophthalmol Soc NZ 1984; 36:33-34
20. Bernstein H, Zvaifler N, Rubin M, Mansour AM. The ocular deposition of chloroquine. Invest Ophthal 1963;2:384-392
21. Zaidman GW. Quinidine keratopathy. Am J Ophthalmol 1984;97:247-249
22. Johnson AW, Buffaloe WJ. Chlorpromazine epithelial keratopathy. Arch Ophthalmol 1966;76:664-667
23. Lullmann H, Lullmann-Rauch R, Wassermann O. Lipidosis induced by amphiphilic cationic drugs. Biochem Pharmacol 1978;27:1103
24. Shah GK, Cantrill HL, Holland EJ. Vortex keratopathy associated with atovaquone. Am J Ophthalmol 1995;120:669-671
25. Hemady RK, Sinibaldi VJ, Eisenberger MA. Ocular symptoms and signs associated with suramin sodium treatment of for metastatic cancer of the prostate. Am J Ophthalmol 1996;121:291-296
26. Szmyd L, Perry HD. Keratopathy associated with the use of naproxen. Am J Ophthalmol 1985;99:598
27. Fitt A, Daya M, Gillie RF. Vortex keratopathy associated with ibuprofen therapy [letter]. Eye 1996;10:145-146
28. Pavlidis NA, Petris C, Briassoulis E, et al. Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients. Cancer 1992;69:2961-2964
29. Imperia PS, Lazarus HM, Lass JH. Ocular complications of systemic cancer chemotherapy. Surv Ophthalmol 1989;34:209-230
30. Higa GM, Gockerman JP, Hunt AL, et al. The use of prophylactic eye drops during high-dose cytosine arabinoside therapy. Cancer 1992;69:2866-2867
31. Rocha G, Brunette I, Le-Francois M. Severe toxic keratopathy secondary to topical anesthetic abuse. Can J Ophthalmol 1995;30:198-202
32. Varga JH, Rubinfeld RS, Wolf TC, et al. Topical anesthetic abuse ring keratitis: report of four cases. Cornea 1997;16:424-429
33. Poulsen EJ, Mannis MJ, Chang SD. Keratitis in methamphetamine abusers. Cornea 1996;15:477-482
34. Zachs R, Zagelbaum BM, Hersch PS. Corneal complications associated with the use of crack cocaine. Ophthalmology 1993;100:187-191
35. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992;99:1647-1654
36. Wong PC, Ruderman JM, Krupin T, et al. 5-Fluorouracil after primary combined filtration surgery. Am J Ophthalmol 1994;117:149-154
37. Federman JL, Schubert HD. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology 1988;95:870-876
38. Phinney RB, Mondino BJ, Hofbauer JD, et al. Corneal edema related to accidental Hi-biclens exposure. Am J Ophthalmol 1988;106:210-215
39. Khurana AK, Ahluwalie BK, Scod S. Savlon keratopathy: a clinical profile. Acta Ophthalmol (Copenh) 1989;67:465-466
40. Zabel RW, Mintsioulis G, MadDonald IM, et al. Corneal toxic changes after cataract extraction. Can J Ophthalmol 1989;24:311-316
41. Smelser GK, Ozanics V. Effect of local anesthetics on cell division and migration following thermal burns of cornea. Arch Ophthalmol 1945;34:271-277
42. Behrendt T. Experimental study of corneal lesions. Am J Ophthalmol 1956;41:99-105
43. Lass JH, Langston RH, Foster CS, Pavan-Langston D. Antiviral medications and corneal wound healing. Antiviral Res 1984;4:143-157
44. Wilson FM II. Adverse external ocular effects of topical ophthalmic medications. Surv Ophthalmol 1979;24:57-88
45. Binder PS, Rasmussen DM, Gordon M. Keratoconjunctivitis and soft contact lens solutions. Arch Ophthalmol 1981;99:87-90
46. Tonjum AM. Effects of benzalkonium chloride upon the corneal epithelium studies with scanning electron microscopy. Acta Ophthalmol 1975;53:358-366
47. Schwab IR, Abbott RL. Toxic ulcerative keratopathy. An unrecognized problem. Ophthalmology 1989;96:1187-1193
48. Ghosh M, McCulloch C. Whorl-like degeneration of corneal epithelium: a clinico-pathologic study. Can J Ophthalmol 1978;13:110-119
49. Lempa MA, Mathers WD. Corneal epithelial cell movement in humans. Eye 1989;3:438-445
50. Kawakami J, Katakami C, Yamamoto M. Capsaicin-induced corneal epithelial changes in rats. Nippon Ganka Gakkai Zasshi 1996;100:653-659
51. Lass JH, Greiner JV, Reinhart WJ, et al. Phosphatic metabolism and corneal edema. Cornea 1991;10:346-353
52. Risco JM, Millar LC. Ultrastructural alterations in the endothelium in a patient with topical anesthetic abuse keratopathy. Ophthalmology 1992;99:628-633
53. Coster DJ. Superficial keratopathy. In: Tasman W, ed. Duane's clinical ophthalmology. Philadelphia: Lippincott, 1991:1-13
54. Nishida T, Ohashi Y, Awata T, Manage R. Fibronectin: a new therapy for corneal trophic ulcer. Arch Ophthalmol 1983;101:1046-1048
55. Charlton JF, Schwab IR, Stuchell R. Topical urea as a treatment of non-infectious keratopathy. Acta Ophthalmol Scand 1996;74:391-394
56. Brown SM, Lamberts DW, Reid TW, et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1 [letter]. Arch Ophthalmol 1997;115:926-927
57. Ohashi Y, Matsuda M, Hosotani H, et al. Aldose reductase inhibitor eyedrops for diabetic corneal epitheliopathy. Am J Ophthalmol 1988;105:233-238